Trials

University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.

It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.

  • IBD Bioresource

    The Inflammatory Bowel Disease BioResource: Progressing from Genetics to Function and Clinical Translation in Crohn’s Disease & Ulcerative Colitis

    View Trial
  • The Reproductive Life Course Project V1.0

    Disorders of Human Reproductive Development: Characterisation and Psychosocial Outcomes (Reproductive Life Course Project)

    View Trial
  • The consequences of SDHA fusion gene on tumorigenesis and tumour metabolism in well differentiated retroperitoneal liposarcoma

    View Trial
  • SIOP – PNET5 MB – LR

    An International Prospective Study on Clinically Standard-risk Medulloblastoma in Children Older Than 3 To 5 Years With Low-risk Biological Profile (pnet 5 Mb – Lr) Or Average-risk Biological Profile (pnet 5 Mb -sr)

    View Trial
  • A local service evaluation to describe the impact of Abbvie Care on NHS resource use in inflammatory bowel disease rheumatoid arthritis psoriasis psoriatic arthritis or ankylosing spondylitis

    View Trial
  • RAPPER

    Radiogenomics: Assessment of polymorphisms for predicting the effects of radiotherapy

    View Trial
  • International Guillain-Barre Syndrome Outcome Stud

    Clinical and biological determinants of disease course in Guillain-Barre syndrome: a prospective UK-wide observational study interfacing with the International Guillain-Barre syndrome Outcome Study – IGOS

    View Trial
  • PROFILE

    PRedicting Outcomes For Crohn’s dIsease using a moLecular biomarkEr (PROFILE) trial

    View Trial
  • A comparative qualitative study of patients’ experiences of cancer diagnosis in England Denmark and Sweden: can comparative analysis of patients’ narratives help us identify how to improve cancer services?

    View Trial
  • Artificial Intelligence in Brain Tumour Imaging

    View Trial